EQS-News: Biotest AG / Key word(s): Annual Report Biotest AG increases sales by 6% in financial year 2024 31.03.2025 / 07:00 CET/CEST The issuer is solely
Biotest is a Germany-based biotechnology company that develops and commercializes plasma protein products and biotherapeutic drugs for the treatment of cancer.